SCHEMBL3215341

SCHEMBL3215341

CC(CCc1ccccc1)Cc1ccc(O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 2/20 0.59
KDM4E B2RXH2 1/20 0.58
SIGMAR1 Q99720 1/20 0.56
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ADRA1A P35348 3/20 0.50
SLC6A2 P23975 2/20 0.50
LMNA P02545 1/20 0.50
ADRB2 P07550 1/20 0.50
ADRB1 P08588 1/20 0.50
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
ADRA2B P18089 1/20 0.50
ADRA2C P18825 1/20 0.50
HTR2A P28223 1/20 0.50
OPRM1 P35372 1/20 0.50
DRD3 P35462 1/20 0.50
HTR2B P41595 1/20 0.50
SLC6A3 Q01959 1/20 0.50
KCNH2 Q12809 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6255974 0.93 TAAR1 (0.55) OPRK1KDM4ESIGMAR1MEN1KMT2A
SCHEMBL28445715 0.90 SIGMAR1 (0.61) OPRK1KDM4ESIGMAR1ADRA1AOPRM1
SCHEMBL3082123 0.89 SIGMAR1 (0.52) SIGMAR1MEN1KMT2ASLC6A2SLC6A3
SCHEMBL28452098 0.87 TAAR1 (0.57) OPRK1KDM4ESIGMAR1ADRA1ASLC6A2
SCHEMBL21693515 0.86 ESR1 (0.50) OPRK1KDM4ESIGMAR1SLC6A2LMNA
SCHEMBL11182514 0.84 OPRK1 (0.47) OPRK1KDM4EMEN1KMT2AADRA1A
SCHEMBL6547008 0.84 ALDH1A1 (0.49) SIGMAR1MEN1KMT2ASLC6A2SLC6A3
SCHEMBL11289313 0.84 TP53 (0.52) SIGMAR1MEN1KMT2ASLC6A2SLC6A3
SCHEMBL6546874 0.84 ALDH1A1 (0.49) SIGMAR1MEN1KMT2ASLC6A2SLC6A3
SCHEMBL19221800 0.82 OPRK1 (0.46) OPRK1KDM4ESIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105929642-B Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and method of manufacturing electrophotographic photosensitive member 佳能株式会社 2020-09-01 CN disclosed
EP-2088138-B1 Process for producing isocyanate ASAHI KASEI CHEMICALS CORP (JP) 2013-02-27 EP disclosed
US-8362293-B2 Process for producing isocyanates ASAHI KASEI CHEMICALS CORPORATION (JP) 2013-01-29 US disclosed
US-20100069665-A1 PROCESS FOR PRODUCING ISOCYANATES AHAHI KASEI CHEMICALS CORPORATION (JP) 2010-03-18 US disclosed
EP-2088138-A1 PROCESS FOR PRODUCING ISOCYANATE Asahi Kasei Chemicals Corporation (JP) 2009-08-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069665-A1 PROCESS FOR PRODUCING ISOCYANATES CPS1, IDH2, PHGDH OPRK1 4445/4885KDM4E 1511/4885SIGMAR1 2942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.